Employment of Salmonella in Cancer Gene Therapy

Area of Science:

• Oncology
• Microbiology
• Gene Therapy

Background:

• Cancer gene therapy faces challenges with selective delivery of therapeutic genes to tumor cells.
• Developing tumor-targeting vectors that spare normal cells is crucial for improving therapeutic efficacy.
• Certain anaerobic bacteria exhibit selective proliferation within tumors, offering potential as therapeutic vectors.

Purpose of the Study:

• To evaluate attenuated Salmonella as a vector for tumor-targeted gene therapy.
• To assess the tumoricidal and anti-angiogenic gene delivery capabilities of Salmonella in preclinical models.
• To investigate polymer modification of Salmonella to overcome host immune responses and enhance tumor gene delivery.

Main Methods:

• Utilized attenuated Salmonella engineered to carry a eukaryotic expression plasmid encoding an anti-angiogenic gene.
• Tested Salmonella's tumor targeting and gene delivery efficacy in murine tumor models.
• Explored the use of polymers to shield Salmonella from host immunity for improved delivery.

Main Results:

• Attenuated Salmonella demonstrated selective tumor targeting and gene delivery capabilities.
• The engineered Salmonella exhibited both tumoricidal and anti-angiogenic activities.
• Polymer modification showed potential in enhancing Salmonella's ability to evade immune responses for better tumor delivery.

Conclusions:

• Attenuated Salmonella serves as a promising vector for targeted cancer gene therapy.
• Delivery of therapeutic genes with tumoricidal and anti-angiogenic functions via Salmonella is a viable strategy.
• Overcoming host immune responses through vector modification can further enhance the effectiveness of bacterial-based cancer therapies.